Legendre, Christophe
Hôpital Necker-Enfants Malades · Centre National de la Recherche Scientifique · Inserm · Université Paris Cité · Institut Necker Enfants Malades · Assistance Publique – Hôpitaux de Paris
4 papers on CoChatORCID 0000-0002-1743-2948
Most cited papers
- Verified
Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
Canaud, G., Bienaimé, F., Tabarin, F., Bataillon, G., Seilhean, D., Noël, L.-H., Dragon-Durey, M.-A., Snanoudj, R., Friedlander, G., Halbwachs-Mecarelli, L., et al. (2014) · New England Journal of Medicine
Systemic Lupus Erythematosus ResearchRenal Transplantation Outcomes and Treatments
Cited by 355
- Verified
Adverse events associated with mTOR inhibitors
Pallet, N., & Legendre, C. (2013) · Expert Opinion on Drug Safety
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies
Cited by 198
- Verified
Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐1
Cohen, C., Le Goff, O., Soysouvanh, F., Vasseur, F., Tanou, M., Nguyen, C., Amrouche, L., Le Guen, J., Saltel‐Fulero, O., Meunier, T., et al. (2021) · EMBO Molecular Medicine
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 79
- Verified
Acquired flucytosine resistance during combination therapy with caspofungin and flucytosine for Candida glabrata cystitis
Charlier, C., El Sissy, C., Bachelier-Bassi, S., Scemla, A., Quesne, G., Sitterlé, E., Legendre, C., Lortholary, O., & Bougnoux, M.-E. (2016) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free